Northwestern Mutual Wealth Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.17M Buy
49,020
+126
+0.3% +$11.2K ﹤0.01% 791
2025
Q4
$4.27M Sell
48,894
-10,000
-17% -$818K ﹤0.01% 821
2025
Q3
$3.91M Sell
58,894
-20,000
-25% -$1.14M ﹤0.01% 808
2025
Q2
$4.36M Hold
78,894
﹤0.01% 715
2025
Q1
$3.82M Hold
78,894
﹤0.01% 733
2024
Q4
$3.05M Hold
78,894
﹤0.01% 742
2024
Q3
$3.55M Sell
78,894
-78,894
-50% -$3.19M ﹤0.01% 698
2024
Q2
$5.47M Buy
+157,788
New +$4.62M 0.01% 572
2024
Q1
Sell
-100
Closed -$2.29K 3768
2023
Q4
$2.29K Buy
+100
New +$1.75K ﹤0.01% 3034
2022
Q1
Sell
-16
Closed -$1K 3336
2021
Q4
$1K Buy
+16
New +$506 ﹤0.01% 3059

Other funds holding PTGX